Form 8-K - Current report:
SEC Accession No. 0001789769-23-000083
Filing Date
2023-08-14
Accepted
2023-08-14 07:01:00
Documents
14
Period of Report
2023-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K til-20230814.htm   iXBRL 8-K 33360
2 EX-99.1 q2-23er.htm EX-99.1 84702
6 LOGO image.jpg GRAPHIC 3565
  Complete submission text file 0001789769-23-000083.txt   266036

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT til-20230814.xsd EX-101.SCH 1892
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT til-20230814_lab.xml EX-101.LAB 25850
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT til-20230814_pre.xml EX-101.PRE 13576
8 EXTRACTED XBRL INSTANCE DOCUMENT til-20230814_htm.xml XML 3091
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Filer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40215 | Film No.: 231166171
SIC: 2836 Biological Products, (No Diagnostic Substances)